Diabetes

Finnish study finds those diagnosed in late teens have more complications, higher mortality than those diagnosed younger

Among older patients with type 2 diabetes who initiate antihyperglycemic therapy, the likelihood of experiencing a cardiovascular event at two years is 33% higher in those who start sulfonylurea monotherapy than in those whose first therapy is metformin, new data suggest.

Device used to determine whether diagnostic testing for diabetes is necessary.

Drug indicated for improving glycemic control in adults with type 2 diabetes.

Despite initial worries, gliptins demonstrate cardioprotective effects

HbA1c lowering less than expected, but researchers note side-effect profile and injection frequency are attractive features

Concerns that the addition of insulin to type 2 diabetes patients already on the new injectable glucagon-like peptide (GLP-1) liraglutide could result in weight gain may not be warranted, researchers suggested here.

While finding may not be surprising, the question becomes how to intervene to help patients